Navigation Links
New consensus on work-related asthma
Date:9/23/2008

In a new consensus statement, the American College of Chest Physicians offers guidance on the diagnosis and treatment of work-related asthma (WRA), a chronic respiratory condition that includes occupational asthma and work-exacerbated asthma (WEA) and affects as many as 25 percent of adults with asthma. Published as a supplement to the September issue of CHEST, the consensus statement, updated from 1995, places new emphasis on

  1. preventive measures, including better control of exposures;
  2. the need for a combination of diagnostic testing; and
  3. the importance of obtaining a full medical and occupational history in patients with suspected WRA.

The statement also places greater consideration on the diagnosis and management of WEA, which is preexisting or concurrent asthma that is worsened by work-related conditions. Developed by an expert panel of specialists in allergy, pulmonary medicine, and occupational medicine, the consensus statement provides supplemental materials, including a worker/workplace fact sheet and physician flow sheets to help physicians and other health-care providers diagnose and manage WRA. For more information related to the ACCP consensus statement on work-related asthma, visit www.chestjournal.org.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Page: 1

Related biology technology :

1. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
2. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
3. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
4. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
5. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
6. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
10. Drug Reduces Airway Mucus in Preclinical Asthma Model
11. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):